Ramsay Générale de Santé SA
EPA:GDS.PA
13.25 (EUR) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 5,006.5 | 4,701.5 | 4,301 | 4,022.6 | 3,746.2 | 3,401.1 | 2,241.5 | 2,234.4 | 2,226.9 | 1,711.6 | 1,869.7 | 1,928.6 | 1,955 | 1,926.1 | 2,046.2 | 1,983.8 | 1,906 | 1,741.5 | 1,435.5 | 1,250.2 |
Cost of Revenue
| 1,063.9 | 978.8 | 890.7 | 818.6 | 731.6 | 644.7 | 450 | 445 | 449.2 | 343.6 | 347.2 | 362 | 374 | 366.1 | 394.1 | 396.6 | 372.8 | 337.5 | 264.6 | 229.6 |
Gross Profit
| 3,942.6 | 3,722.7 | 3,410.3 | 3,204 | 3,014.6 | 2,756.4 | 1,791.5 | 1,789.4 | 1,777.7 | 1,368 | 1,522.5 | 1,566.6 | 1,581 | 1,560 | 1,652.1 | 1,587.2 | 1,533.2 | 1,404 | 1,170.9 | 1,020.6 |
Gross Profit Ratio
| 0.787 | 0.792 | 0.793 | 0.796 | 0.805 | 0.81 | 0.799 | 0.801 | 0.798 | 0.799 | 0.814 | 0.812 | 0.809 | 0.81 | 0.807 | 0.8 | 0.804 | 0.806 | 0.816 | 0.816 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 83.1 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 82 | 698.5 | 84.6 | 85.9 | 89.4 | 260.1 | 189.9 | 488.6 | 473.3 | 141.1 | 156.8 | 0 | 0 | 83.1 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Expenses
| 3,758.4 | 95.9 | 3,117.4 | 2,945.4 | 2,829.9 | 2,599.5 | 1,665.8 | -1 | -0.2 | -0.7 | -0.7 | -2.8 | 1,436.6 | -5 | 1,536 | 1,426.8 | 1,398.5 | -2.6 | 1,071.1 | 0.3 |
Operating Expenses
| 3,758.4 | 3,503.1 | 3,117.4 | 2,945.4 | 2,829.9 | 2,599.5 | 1,665.8 | 1,656.9 | 1,638.7 | 1,271.9 | 1,418.1 | 1,451.4 | 1,436.6 | 1,414.2 | 1,536 | 1,426.8 | 1,398.5 | 1,082.9 | 1,071.1 | 949.1 |
Operating Income
| 184.2 | 218.2 | 281.1 | 272 | 184.7 | 156.9 | 125.7 | 132.5 | 139 | 96.1 | 104.4 | 115.2 | 50.3 | 103.9 | 131.4 | 160.4 | 106.8 | 313.1 | 92.4 | 71.8 |
Operating Income Ratio
| 0.037 | 0.046 | 0.065 | 0.068 | 0.049 | 0.046 | 0.056 | 0.059 | 0.062 | 0.056 | 0.056 | 0.06 | 0.026 | 0.054 | 0.064 | 0.081 | 0.056 | 0.18 | 0.064 | 0.057 |
Total Other Income Expenses Net
| -225 | -130.6 | -95.9 | -168.7 | -138.9 | -108.6 | -103.2 | -38.6 | -71.9 | -43.3 | -42.5 | -19.6 | -238.9 | -89.7 | -59.6 | -75.4 | -28.6 | -28.6 | -24.6 | -23.6 |
Income Before Tax
| -40.8 | 87.6 | 185.2 | 103.3 | 45.8 | 48.3 | 22.5 | 93.9 | 67.1 | 52.8 | 128 | 95.6 | -0.4 | 52.5 | 71.8 | 85 | 78.2 | 284.5 | 67.8 | 48.2 |
Income Before Tax Ratio
| -0.008 | 0.019 | 0.043 | 0.026 | 0.012 | 0.014 | 0.01 | 0.042 | 0.03 | 0.031 | 0.068 | 0.05 | -0 | 0.027 | 0.035 | 0.043 | 0.041 | 0.163 | 0.047 | 0.039 |
Income Tax Expense
| -4.1 | 23.8 | 57.3 | 29.5 | 27.1 | 33 | 8.5 | 29 | 24.9 | 29.7 | 13.2 | 36.5 | 25.3 | 14.6 | 26.5 | -5.1 | 29.7 | 55.6 | 24.7 | 20.5 |
Net Income
| -53.9 | 49.4 | 118.4 | 65 | 18.7 | 15.3 | 7.3 | 57 | 36.9 | 19.7 | 111.3 | 55.7 | -28.5 | 37.9 | 42.4 | 87.2 | 45.6 | 225.4 | 40.9 | 27.4 |
Net Income Ratio
| -0.011 | 0.011 | 0.028 | 0.016 | 0.005 | 0.004 | 0.003 | 0.026 | 0.017 | 0.012 | 0.06 | 0.029 | -0.015 | 0.02 | 0.021 | 0.044 | 0.024 | 0.129 | 0.028 | 0.022 |
EPS
| -0.49 | 0.45 | 1.07 | 0.59 | 0.17 | 0.18 | 0.096 | 0.7 | 0.45 | 0.32 | 1.83 | 0.92 | -0.47 | 0.58 | 0.71 | 1.48 | 0.78 | 4.2 | 0.97 | 0.65 |
EPS Diluted
| -0.49 | 0.45 | 1.07 | 0.59 | 0.17 | 0.18 | 0.096 | 0.7 | 0.45 | 0.32 | 1.83 | 0.92 | -0.47 | 0.58 | 0.71 | 1.48 | 0.76 | 4.15 | 0.96 | 0.65 |
EBITDA
| 584.9 | 621 | 666.5 | 627.6 | 547.1 | 330.6 | 254.1 | 273.7 | 250.7 | 205.5 | 291.9 | 237.8 | 362 | 262.3 | 233.8 | 275.8 | 246.3 | 414.1 | 181.8 | 154.6 |
EBITDA Ratio
| 0.117 | 0.132 | 0.155 | 0.156 | 0.146 | 0.097 | 0.113 | 0.122 | 0.113 | 0.12 | 0.156 | 0.123 | 0.185 | 0.136 | 0.114 | 0.139 | 0.129 | 0.238 | 0.127 | 0.124 |